(Q47733029)

5 February 2018

title

Beta-sheet breaker peptide prevents Abeta-induced spatial memory impairments with partial reduction of amyloid deposits (English)

1 reference

5 February 2018

1 reference

Chacón MA

1

1 reference

5 February 2018

Barría MI

series ordinal

2

1 reference

5 February 2018

Soto C

series ordinal

3

1 reference

5 February 2018

Inestrosa NC

series ordinal

4

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 October 2004

1 reference

5 February 2018

published in

Molecular Psychiatry

1 reference

5 February 2018

volume

9

1 reference

5 February 2018

issue

10

1 reference

5 February 2018

page(s)

953-961

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001516

exact match

0 references

cites work

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Nerve inflammation halts trial for Alzheimer's drug.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Call for Elan to publish Alzheimer's trial details.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Cerebral hemorrhage after passive anti-Abeta immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Laminin inhibits amyloid-beta-peptide fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Laminin affects polymerization, depolymerization and neurotoxicity of Abeta peptide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Inhibition of Alzheimer beta-fibrillogenesis by melatonin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

?1-Antichymotrypsin Binding to Alzheimer A? Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Fullerene inhibits beta-amyloid peptide aggregation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Type IV collagen prevents amyloid beta-protein fibril formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Arrest of beta-amyloid fibril formation by a pentapeptide ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Developments of a water-maze procedure for studying spatial learning in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Methods for staining amyloid in tissues: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Wnt signaling involvement in beta-amyloid-dependent neurodegeneration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Alzheimer's vaccine: a cure as dangerous as the disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Toxicity of beta-amyloid vaccination in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

In vivo reversal of amyloid-beta lesions in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001516

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001516

1 reference

5 February 2018

1 reference

5 February 2018